Hims & Hers Health, Inc. HIMS Chief Executive

What Andrew Dudum says in public, and what their own SEC filings show they own.

Andrew Dudum

Co-founder & CEO · Hims & Hers Health, Inc.

Founded Hims in 2017; previously co-founder of Atomic, a venture studio; leads company vision and strategy.

What they own

Ownership

Skin in the game
47/ 70
Level 3Stakeholder

Dudum owns about 19% of Hims & Hers Health, Inc., worth $1.28B at the last close.

SEC filings
123
Stake 42.9M reported shares ≈ 18.8% of shares outstanding — no 13G on file, so an estimate 35/35
Founder Not assessed — whether they founded the company has not been researched Not assessed
Tenure No start date on record, so tenure scores nothing 0/10
Track record Not assessed — their prior companies have not been researched Not assessed
Direction No open-market buys or sales in the last year 5/15
Discipline 2 late Form 4s in 123 filings 7/10

Nobody has researched this person's career yet, so founder and track record are left out of the score and of the total above.

Score = stake band (35) + founder (15) + tenure (10) + track record (15) + 12-month direction (−10…15) + filing discipline (10). An axis we have not researched is left out of the score and of the total it is shown over. Every input links to a filing or to our own research; the bands are ours.

Reported · Forms 3, 4, 5 42.9M Every lot on the person's own filings, as of Aug 27, 2026
Paper trail 2 late filings Form 4 covering a 2025-01-16 option or RSU conversion in Hims & Hers Health, Inc. was filed 2025-01-23, 4 business days later; Section 16 allows two.
Reported Hims & Hers Health, Inc. shares Forms 3, 4 and 5 · as of 2026-08-27
020M40M60M 202120222023202420252026 Aug 2026: net −901,432 shares across 4 movements (largest: other −977,566)Jun 2026: net +69,359 shares across 2 movements (largest: exercise +154,991)Apr 2026: net 0 shares across 2 movements (largest: gift −422,933)Mar 2026: net −362,117 shares across 2 movements (largest: tax −526,486) 42.9M

Dots mark the months the activity below moved the line. Hover one for that month's net move, how many movements it folds and the largest.

How the stake is held
SecurityHeld viaShares
Class V Common StockHeld by Andrew Dudum 2015 Trust Dated July 2, 20158,377,623
Class A Common StockHeld by Atomic Labs II, L.P.8,280,910
Class A Common StockHeld by Andrew Dudum 2015 Trust Dated July 2, 20158,207,151
Class A Common StockHeld by Trustee of Dudum Family 2021 Trust3,004,071
Class A Common StockHeld by AD GRAT dated 8/31/202,866,230
Class A Common StockHeld by Trustee of Dudum Family Heritage Trust UAD 8-10-20212,214,769
Class A Common StockHeld by Trustee of AD 2023 GRAT dated 9-1-20231,584,506
Class A Common StockHeld by Trustee of AD 2022 GRAT 31,315,881
Class A Common StockHeld by Trustee of the AD GRAT dated 8/31/201,121,033
Class A Common StockHeld by Trustee of AD 2022 GRAT 3 dated 11-28-20221,078,549
Class A Common StockDirect1,033,177
Class V Common StockHeld by Trustee of the AD 2023 GRAT dated 9-1-2023888,719
Class A Common StockHeld by Trustee of AD 2022 GRAT 2 dated 9/7/2022791,117
Class A Common StockHeld by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015573,202
Class A Common StockHeld by Trustee of Dudum Family Community Property Trust470,457
Class A Common StockHeld by Trustee of AD 2022 GRAT463,289
Class A Common StockHeld by Trustee of AD 2021 GRAT 2 dated 11-1-2021262,423
Class A Common StockHeld by Trustee of AD 2025 GRAT 3 dated 5-27-2025186,723
Class A Common StockHeld by Trustee of Dudum Legacy 2021 Trust103,406
Class A Common StockHeld by Trustee of AD 2025 GRAT dated 5-27-202542,993
Class A Common StockHeld by Trustees of Richard M. Dudum Irrevocable 1 U/A dtd 10/15/19971,500
Reported as of 2026-08-2742,867,729
Held directly
2%
Vehicles
19 trusts or entities
Share classes
2
Last filing
Aug 27, 2026
Activity · last 12 months 10 events folded from 48 filing lines · Every filing on EDGAR ↗
DateTypeWhat happenedSharesPriceValueNote
Aug 27, 2026 filing: Other, Other acquisition or disposition · Class A Common Stock Other Other acquisition or disposition · Class A Common Stock −977,566 — — Through Held by Trustee of Dudum Legacy 2021 Trust
Aug 25, 2026 filing: Gift, Gift · Class A Common Stock Gift Gift · Class A Common Stock −463,289 — — Through Held by Trustee of AD 2022 GRAT
Aug 14, 2026 filing: Exercise, Option or RSU conversion · Class A Common Stock Exercise Option or RSU conversion · Class A Common Stock +154,993 — —
Aug 14, 2026 filing: Tax, Shares withheld for tax · Class A Common Stock Tax Shares withheld for tax · Class A Common Stock −78,859 $28.15 $2.2M
Jun 15, 2026 filing: Exercise, Option or RSU conversion · Class A Common Stock Exercise Option or RSU conversion · Class A Common Stock +154,991 — —
Jun 15, 2026 filing: Tax, Shares withheld for tax · Class A Common Stock Tax Shares withheld for tax · Class A Common Stock −85,632 $30.17 $2.6M
Apr 9, 2026 filing: Gift, Gift · Class A Common Stock Gift Gift · Class A Common Stock −422,933 — —
Apr 9, 2026 filing: Gift, Gift · Class A Common Stock Gift Gift · Class A Common Stock +422,933 — — Through Held by Trustee of Dudum Family Community Property Trust
Mar 13, 2026 filing: Tax, Shares withheld for tax across 2 lots · Class A Common Stock Tax Shares withheld for tax across 2 lots · Class A Common Stock −526,486 $24.77 $13.0M
Mar 13, 2026 filing: Exercise, Option or RSU conversion · Class A Common Stock Exercise Option or RSU conversion · Class A Common Stock +164,369 — —
Every issuer Andrew Dudum files as an insider of
CompanyRoleReportedBeneficial% of class
HIMS Hims & Hers Health, Inc. This page Chief Executive Officer 43M
2026-08-27
— —

Reported is every lot on the person's own Forms 3, 4 and 5 — direct and through trusts. Beneficial is the figure stated on the latest Schedule 13D/G cover page, which can exclude shares the person disclaims and include options exercisable within 60 days, so the two are never added together.

Paper trail

123 filings under CIK 0001837796 · captured 2026-09-05 · All filings on EDGAR ↗

On the record with shareholders

Earnings calls

  1. Q2 2026 Aug 10, 2026 Andrew Dudum's argument was that scale has become the product. With nearly three million subscribers, he said Hims & Hers now carries a patient population rivalling large US health systems, and that nine years of closed-loop data — not a bolted-on chatbot — is what makes an AI-native care platform defensible. He asked to be judged on what that platform buys rather than on the quarter's GAAP loss: engagement up threefold and non-clinical support tasks down by half in the first Hers rollout, savings he intends to hand back as lower weight-loss prices; men's hormonal health compounding toward a $100 million run rate; and a peptide business built out to clinical protocols and US manufacturing but deliberately held back until the FDA finishes rulemaking. The gross-margin compression and the loss, on his telling, are the price of buying that position now. Read the call · 4 quotes →
In their own words

Podcasts, interviews & articles

3 recorded appearances

2026

Interview CNBC Squawk Box · Aug 18, 2026 · 24 min

Watch CNBC's full interview with Hims & Hers CEO Andrew Dudum, Aug 18, 2026

Dudum defends the company against the FTC's lawsuit, explains the shift from compounded to branded GLP-1s, and says he expects cash-pay monthly costs to fall to roughly $40-50 from $150-200. He also says Hims is building its own AI infrastructure instead of paying third-party agent vendors.

Watch or read: Watch CNBC's full interview with Hims & Hers CEO Andrew Dudum, Aug 18, 2026 →
Podcast 20VC with Harry Stebbings · Apr 4, 2026 · 1h 4m

How Hims & Hers Reached a $4.3BN Market Cap on $2.3BN of Revenue | Andrew Dudum, Apr 4, 2026

Recorded after a roughly 66% drawdown in the stock, Dudum argues being public is a net advantage, dismisses the dedicated "strategy" hire, contends brand marketing beats performance marketing, and defends the $1.5B acquisition of international rival Eucalyptus.

Watch or read: How Hims & Hers Reached a $4.3BN Market Cap on $2.3BN of Revenue | Andrew Dudum, Apr 4, 2026 →

Who else runs a company like this one

Every CEO we track →